|Page (1) of 1 - 03/05/18||email article||print page|
Ovid Therapeutics to Present at Two Upcoming Investor Conferences(March 05, 2018)
NEW YORK, March 05, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company committed to developing medicines for patients with rare neurological disorders, today announced that members of the company’s management team will present at two upcoming investor conferences:
- Cowen & Company 38th Annual Health Care Conference
Jeremy Levin, DPhil, MB BChir, chairman and chief executive officer of Ovid, will present a corporate overview on Monday, March 12, 2018 at 2:10 p.m. ET. The conference will be held at the Boston Marriott Copley Place Hotel in Boston, MA.
- BioCentury’s 25th Annual Future Leaders in the Biotech Industry ConferenceYaron Werber, M.D., chief business and financial officer of Ovid, will present a corporate overview on Friday, March 23, 2018 at 10:00 a.m. ET. The conference will be held at the Millennium Broadway Hotel & Conference Center in New York, NY.
Live audio webcasts of the presentations can be accessed through the Events & Presentations section of the company's website at investors.ovidrx.com. Archived replays of the webcasts will be available on the company's website for two weeks following each live presentation.
About Ovid Therapeutics
For more information on Ovid, please visit http://www.ovidrx.com/.
Steve Klass, 212-213-0006
Pure Communications, Inc.
Katie Engleman, 910-509-3977